These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21846853)

  • 1. Use of radioactive iodine for thyroid cancer.
    Haymart MR; Banerjee M; Stewart AK; Koenig RJ; Birkmeyer JD; Griggs JJ
    JAMA; 2011 Aug; 306(7):721-8. PubMed ID: 21846853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between extent of thyroid cancer surgery and use of radioactive iodine.
    Haymart MR; Banerjee M; Yang D; Stewart AK; Doherty GM; Koenig RJ; Griggs JJ
    Ann Surg; 2013 Aug; 258(2):354-8. PubMed ID: 23567930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgeon training and use of radioactive iodine in stage I thyroid cancer patients.
    Schuessler KM; Banerjee M; Yang D; Stewart AK; Doherty GM; Haymart MR
    Ann Surg Oncol; 2013 Mar; 20(3):733-8. PubMed ID: 23224826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease severity and radioactive iodine use for thyroid cancer.
    Haymart MR; Muenz DG; Stewart AK; Griggs JJ; Banerjee M
    J Clin Endocrinol Metab; 2013 Feb; 98(2):678-86. PubMed ID: 23322816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
    Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
    Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation.
    Oltmann SC; Schneider DF; Leverson G; Sivashanmugam T; Chen H; Sippel RS
    Ann Surg Oncol; 2014 Apr; 21(4):1379-83. PubMed ID: 24378987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparity in the use of adjuvant radioactive iodine ablation among high-risk papillary thyroid cancer patients.
    Moten AS; Zhao H; Intenzo CM; Willis AI
    Eur J Surg Oncol; 2019 Nov; 45(11):2090-2095. PubMed ID: 31253543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma.
    Song JSA; Moolman N; Burrell S; Rajaraman M; Bullock MJ; Trites J; Taylor SM; Rigby MH; Hart RD
    Head Neck; 2018 Oct; 40(10):2129-2136. PubMed ID: 29756327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors that influence radioactive iodine use for thyroid cancer.
    Papaleontiou M; Banerjee M; Yang D; Sisson JC; Koenig RJ; Haymart MR
    Thyroid; 2013 Feb; 23(2):219-24. PubMed ID: 23134514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States.
    Sawka AM; Rotstein L; Brierley JD; Tsang RW; Thabane L; Gafni A; Straus S; Kamalanathan S; Zhao B; Goldstein DP; Rambaldini G; Ezzat S
    Thyroid; 2007 Dec; 17(12):1235-42. PubMed ID: 17988197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
    Scheffel RS; Zanella AB; Dora JM; Maia AL
    Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer.
    Wallner LP; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Lubitz C; Hawley ST; Haymart MR
    J Clin Endocrinol Metab; 2021 May; 106(6):e2402-e2412. PubMed ID: 33687063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Too Much of a Good Thing: Radioactive Iodine Ablation Use for Micropapillary Thyroid Carcinoma.
    Chae AW; Martinez SR
    Am Surg; 2018 May; 84(5):637-643. PubMed ID: 29966562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of socioeconomic status on the use of adjuvant radioactive iodine for papillary thyroid cancer.
    Zevallos JP; Xu L; Yiu Y
    Thyroid; 2014 Apr; 24(4):758-63. PubMed ID: 24378070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.
    Holoubek SA; MacKinney EC; Khokar AM; Kuchta KM; Winchester DJ; Prinz RA; Moo-Young TA
    Surgery; 2022 Jan; 171(1):203-211. PubMed ID: 34384604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma.
    Kim M; Kim BH; Kim JM; Kim EH; Kim K; Pak K; Jeon YK; Kim SS; Park H; Kang T; Lee BJ; Kim IJ
    Cancer; 2019 Aug; 125(16):2803-2809. PubMed ID: 31216369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer.
    Haymart MR; Banerjee M; Yang D; Stewart AK; Koenig RJ; Griggs JJ
    Cancer; 2013 Jan; 119(2):259-65. PubMed ID: 22744940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study.
    Liu X; Fan Y; Liu Y; He X; Zheng X; Tan J; Jia Q; Meng Z
    Updates Surg; 2020 Sep; 72(3):871-884. PubMed ID: 32342347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the management of thyroid cancer.
    Haymart MR; Banerjee M; Yang D; Stewart AK; Sisson JC; Koenig RJ; Doherty GM; Griggs JJ
    J Clin Endocrinol Metab; 2013 May; 98(5):2001-8. PubMed ID: 23539722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.